The literature on both human and rodent models has revealed that alterations of NPY levels in the brain are related to several neurodegenerative and neuroimmune diseases such as AD, PD, HD, and Machado–Joseph disease (MJD) [153]. The gene discussed is NPY; the disease is Alzheimer disease.